emerging infections

Dr. David Shlaes, an infectious disease expert and ACSH advisor, is incensed over the nation's lack of preparedness for the coronavirus epidemic. A scenario like this has been discussed for three decades, yet we are still in the middle of a disaster. Here are his thoughts.
Genetic engineering, despite its numerous contributions to our health and welfare, continues to face opposition, and sometimes from unexpected sources. The most recent "boogeymen" are genetically modified mosquitoes, which are a critical innovation for protecting us from some very nasty viral diseases. Dr. Henry Miller explains.
Though recent and alarming headlines are touting a global superbug, it can be hard to discern fact from fiction. Should we be worried? Let's take a look and find out.
A team of researchers wants patients to shorten their antibiotic course. This suggestion is problematic, and possibly dangerous, both to individuals and the larger battle against antibiotic resistance. And it goes against the recommendations of many organizations.  
A new study analyzes U.S. vaccination rates in children, specifically focusing on nonmedical exemptions in states and counties. The recommendations, however, fall short of the realities of medical practice.